Phase I/II Evaluation of Safety and Activity of Mylotarg Plus Melphalan and Fludarabine as Preparative Therapy for Older or Medically Infirm Patients Undergoing Allogeneic Bone Marrow and Peripheral Blood Stem Cell Transplantation.
Phase of Trial: Phase I/II
Latest Information Update: 31 Jul 2012
At a glance
- Drugs Gemtuzumab ozogamicin (Primary) ; Antithymocyte globulin; Fludarabine; Melphalan; Methotrexate; Tacrolimus
- Indications Acute myeloid leukaemia; Chronic myeloid leukaemia; Graft-versus-host disease; Myelodysplastic syndromes
- Focus Adverse reactions
- 05 Nov 2009 New trial record